合成生物素化普鲁兰多糖衍生物(BP),采用纳米沉淀法制备纳米颗粒(BPNs),考察制备条件对纳米颗粒性质影响,为进一步将其作为药物载体的研究提供基础.通过酯化反应将生物素羧基与普鲁兰多糖连接,生成的衍生物BP通过FI-IR和1H-NMR表征,取代度采用电感耦合等离子体光谱仪(ICP)确定;BPNs进行透射电镜、动态光散射仪和ζ电位仪表征与检测,颗粒表面生物素采用Quant*TagTM Biotin Kit生物素测定试剂盒测定.获得取代度21(BP1),46(BP2),81(BP3)3种衍生物,其中BP2和BP3能够制备纳米颗粒(LBPNs,HBPNs).纳米颗粒呈球形,表面光滑规整,平均粒径100～300nm,水中ζ电位在一17mV左右.制备过程中,粒径随BP浓度(10～50mg/ml)增加而增加((136.2±46.8)nm,(190.8±89.6)nm和(254.5±140.0)nm).调整水相组成为水:元水乙醇(v/v)1:1和1:2时粒径分别为(170.7±30.4)nm和(158.8±21.0)nm.HBPNs和LBPNs表面的生物素量为衍生物的(1.9±0.03)%和(2.0±0.04)%.生物素化普鲁兰多糖衍生物通过纳米沉淀法能制备出纳米颗粒,颗粒表面存在有生物素,颗粒性质受制备条件影响.
参考文献
| [1] | Sutton G;Blessing J;Hanjani P et al.[J].Gynecologic Oncology,2005,96(03):749-752. |
| [2] | Bellott R;Pouna P;Robert J .[J].Journal of Chromatography B:Biomedical Sciences and Applications,2001,757(02):257-267. |
| [3] | Adler-Moore J;Fujii G;Forssen E A et al.[J].Journal of Controlled Release,1994,28(1-3):303-304. |
| [4] | Micha JP;Goldstein BH;Birk CL;Rettenmaier MA;Brown JV 3rd .Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions.[J].Gynecologic Oncology,2006(2):437-438. |
| [5] | 丁玉琴,郭俊生,赵法伋.多维生素转运体[J].卫生研究,2002(06):481-483. |
| [6] | Na K;Bum Lee T;Park KH;Shin EK;Lee YB;Choi HK .Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system.[J].European journal of pharmaceutical sciences,2003(2):165-173. |
| [7] | Tosi G;Rivasi F;Gandolfi F;Costantino L;Vandelli MA;Forni F .Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles[J].Biomaterials,2005(19):4189-4195. |
| [8] | Jain R K .[J].Science,2005,307(5706):58-62. |
| [9] | RM R;Sharma C P .[J].Artificial Organs,2007,20(02):536. |
| [10] | Shingel K I .[J].Pullulan Carbohydr Res,2004,339(03):447. |
| [11] | Na K;Seong-Lee E;Bae Y H .[J].J Cont Rei,2003,87:3-13. |
| [12] | Caroline D T;Jovenka H T;Guy M T .[J].Colloids and Surfaces A:Physicochemical and Engineering Aspects,2003,220:105-115. |
| [13] | Moreira J M;Almeida L M;Geraldes C F et al.[J].International Journal of Pharmaceutics,1997,147:153-164. |
| [14] | Chen FE;Jia HQ;Chen XX;Dai HF;Xie B;Kuang YY;Zhao JF .Synthetic studies on d-biotin, part 9. An improved asymmetric synthetic route to d-biotin via Hoffmann-Roche lactone-thiolactone approach.[J].Chemical and Pharmaceutical Bulletin,2005(7):743-746. |
| [15] | Choi S W;Kwon H Y;Kim W S et al.[J].Colloids and Surfaces A:Physicochemical and Engineering Aspects,201:283-289. |
| [16] | Thioune O;Fessi H;Devissaguet J P et al.[J].International Journal of Pharmaceutics,146:233-238. |
| [17] | Senichev V Y;Tereshatov V V.[J].ChemTec Publishing,2001:101-124. |
上一张
下一张
上一张
下一张
计量
- 下载量()
- 访问量()
文章评分
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%